ClinicalTrials.Veeva

Menu

Standard of Care Therapy With Involved Field Radiation Therapy for Selective Recurrent Ovarian Cancer

Yonsei University logo

Yonsei University

Status and phase

Unknown
Phase 2

Conditions

Recurrent Ovarian Cancer

Treatments

Radiation: Involved-field radiotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT03618706
4-2018-0299

Details and patient eligibility

About

This study aims to investigate the effect of involved-field radiotherapy for recurrent ovarian cancer after primary standard treatment. We will investigate whether the addition of involved-field RT improves 2-year PFS in those patients than that of historical data (only with other standard salvage treatments as systemic chemotherapy ± maximum tumor resection).

Enrollment

107 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pathologically confirmed ovarian carcinoma
  • Patients who received "standard treatment" for each stage as a primary treatment
  • No. of recurrent lesions:

If, all in lung, or intra-abdominal or pelvis organs - ≤ 5 If, any in liver, bone, or spinal cord - ≤ 2

  • Size of recurrent lesions ≤5 cm
  • All recurrent lesions are available for involved-field radiotherapy
  • Within 60 days before enrollment:
  • Absolute neutrophil count ANC ≥ 500 / mm3
  • Platelet ≥ 50,000 / mm3
  • Hb ≥ 8.0 g / dl
  • Good performance status (ECOG 0-1)

Exclusion criteria

  • Brain metastasis
  • Diffuse peritoneal carcinomatosis
  • Malignant pleural effusion
  • History of previous salvage radiotherapy for recurrent lesions
  • History of other malignancy or severe/unstable medical condition

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

107 participants in 1 patient group

involved-field RT + standard salvage treatment
Experimental group
Description:
Patients receiving involved-field RT on recurred lesions + standard salvage treatment for recurrent ovarian cancer
Treatment:
Radiation: Involved-field radiotherapy

Trial contacts and locations

1

Loading...

Central trial contact

Yong Bae Kim, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems